Clinical Trial Update: A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating once-monthly subcutaneous Mircera (methoxy polyethylene glycol-epoetin beta) for anemia in dialysis patients with chronic kidney dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-10-07